Interim Report H1 2024
August 27, 2024 10:30 ET
|
Novozymes A/S
H1 organic pro forma sales growth at 7%, with pro forma adjusted EBITDA margin at 35.3%. Full-year outlook increased. H1 organic pro forma sales growth of 7% and 8% on IFRS reported basis. Q2...
Novonesis increases outlook for full year 2024
August 27, 2024 10:29 ET
|
Novozymes A/S
Novonesis increases its full-year sales and profitability outlook based on the first half year performance coupled with strong momentum going into the first months of the second half.The 2024 outlook...
Major shareholder announcement
August 16, 2024 10:40 ET
|
Novozymes A/S
Please see the full announcement in PDF
Attachments
2024_25_Major_Shareholders_Announcement
Novozymes B 13 Aug 2024 Final
...
Major shareholder announcement
June 26, 2024 08:08 ET
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis, that as of June 21, BlackRock, Inc. crossed the 5% threshold...
Trading by management and close relations of management
June 21, 2024 05:54 ET
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Major shareholder announcement
June 21, 2024 05:53 ET
|
Novozymes A/S
June 21, 2024 Company announcement No. 22 Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that Novo Nordisk Fonden has on its own behalf and on behalf of its...
The era of biosolutions. Outlook upgraded for 2024
June 17, 2024 13:09 ET
|
Novozymes A/S
Novonesis is performing very well and the 2024 outlook for pro forma organic sales growth is now expected at the upper end of the 5-7% range while the pro forma adjusted EBITDA margin is increased to...
Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees
June 06, 2024 05:28 ET
|
Novozymes A/S
June 6, 2024Company announcement No. 20 Incentive program for the Executive Leadership Team 2024-2026 In line with previous year, a new long-term incentive program (LTI) for the...
Trading by management and close relations of management
May 31, 2024 05:26 ET
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
May 29, 2024 10:59 ET
|
Novozymes A/S
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...